Intrinsiqq

BB Biotech AG (BB.XMIL) Dividend Analysis

Does BB Biotech (BB.XMIL) pay a dividend?

No. BB Biotech (BB.XMIL) paid CHF 1.80 per share in fiscal 2025, and no later dividend appears in its filings.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025CHF 1.80-10.2%
2024CHF 2.00-29.8%
2023CHF 2.85-30.3%
2022CHF 4.09+7.1%
2021CHF 3.82

All 5 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

BB.XMIL
Dividend40
No current dividend

Dividend appears well-covered by both earnings and free cash flow, no sustained growth pattern yet.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

100

Safety

40% of composite

Earnings Payout100
15.6%Well-covered
FCF Coverage100
3.2xVery comfortable
0

Growth

35% of composite

Dividend Streak0
0YNo sustained streak
Growth Rate0
-17.2%Declining
0

Income

25% of composite

Cash Yield (TTM)0
N/ANo data

Composite = Safety (100) × 0.40 + Growth (0) × 0.35 + Income (0) × 0.25 = 40

Dividend Yield

—

Per Share (FY2025)

CHF 1.80

Payout Ratio

15.6%

4Y CAGR

-17.2%

Dividend Safety

Earnings Payout

15.6%

FCF Payout

31.5%

FCF Coverage

3.2x

Dividend Growth

Per Share (FY2025)

CHF 1.80

Growth Streak

—

4Y CAGR

-17.2%

Does BB Biotech (BB.XMIL) pay a dividend?

Frequently asked

Does BB Biotech (BB.XMIL) pay a dividend?+

No. BB Biotech (BB.XMIL) does not currently pay a dividend. The last payment in our data was in 2025, and nothing has been paid since.

How does BB Biotech return cash to shareholders?+

It largely does not. BB Biotech pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could BB Biotech afford to pay a dividend?+

On the numbers, yes. BB Biotech generated CHF 394 million of free cash flow, which is about CHF 7.14 per share. If it paid out half of that, the dividend would be roughly CHF 3.57 per share. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.

Which financials companies do pay dividends?+

Our Financials sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with BB Biotech.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BB.XMIL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.